Corticosteroid

SAN DIEGO — Few patients are evaluated based on all seven endpoints of guidelines indicating complete asthma remission, according to a poster presented at the American Thoracic Society International Meeting.

While both corticosteroids and platelet-rich plasma may be effective treatments for patients with lateral epicondylitis, or tennis elbow, PRP may offer longer-term functional improvements and pain relief, according to published results.

Among patients with bronchiectasis, disease severity was higher with a blood eosinophil count less than 50 cells/L or higher than 300 cells/L, according to results published in CHEST.

WASHINGTON — Swallowed corticosteroid treatment did not impact growth velocity among children with eosinophilic esophagitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Nearly 40% of children with oligoarticular juvenile idiopathic arthritis treated with intra-articular corticosteroids required no additional therapy, according to data published in Arthritis Research & Therapy.

The prevalence of severe persistent asthma among patients with asthma significantly ranges across the United States, from 19.6% in New Mexico to 31.9% in Alaska, according to a study published in Annals of Allergy, Asthma & Immunology.

This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.

Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.

Intranasal corticosteroids did not impact COVID-19 mortality in patients with asthma, COPD or neither, but they did reduce the risk for all-cause mortality, according to study results published in Annals of Allergy, Asthma & Immunology.

Patients with interstitial lung disease and surfactant-related gene mutations showed progressive lung function decline and reduced survival that was comparable to that of other ILD groups, according to results published in CHEST.